These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1704168)

  • 61. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias.
    Panidis I; Morganroth J
    J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmias.
    Morganroth J; Hunter H
    Am Heart J; 1985 Dec; 110(6):1176-81. PubMed ID: 4072874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.
    Chimienti M; Regazzi MB; La Rovere MT; Salerno JA; Previtali M; Montericcio V; Rondanelli R; Montemartini C
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):679-86. PubMed ID: 2484920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration.
    Giani P; Landolina M; Giudici V; Bianchini C; Ferrario G; Marchi S; Riva E; Latini R
    Eur J Clin Pharmacol; 1988; 34(2):187-94. PubMed ID: 3383990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exacerbation of myasthenia by propafenone.
    Lecky BR; Weir D; Chong E
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):377. PubMed ID: 2056335
    [No Abstract]   [Full Text] [Related]  

  • 66. [Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole].
    Victor J; Turcant A; Tadei A; Allain P
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):163-6. PubMed ID: 2436547
    [No Abstract]   [Full Text] [Related]  

  • 67. [Activity of a new long-acting anti-arrhythmic drug on ventricular extrasystole. Study with Holter continuous electrocardiographic monitoring].
    Romano S; Pozzoni L; Verzoni A; Lomuscio A; Guffanti E; Croce L
    G Ital Cardiol; 1981; 11(5):657-62. PubMed ID: 6169582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodialysis removal of propafenone.
    Burgess ED; Duff HJ
    Pharmacotherapy; 1989; 9(5):331-3. PubMed ID: 2813154
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of oral quinidine on left ventricular performance in normal subjects and patients with congestive cardiomyopathy.
    Crawford MH; White DH; O'Rourke RA
    Am J Cardiol; 1979 Oct; 44(4):714-8. PubMed ID: 484501
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute changes in blood pressure as a cause of cardiac arrhythmias.
    Sideris DA; Kontoyannis DA; Michalis L; Adractas A; Moulopoulos SD
    Eur Heart J; 1987 Jan; 8(1):45-52. PubMed ID: 3816838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quinidine dosage, with special reference to an oral loading dose schedule.
    Collste P; Nordlander R
    Br J Clin Pharmacol; 1979 Mar; 7(3):293-7. PubMed ID: 427006
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of quinidine Lipettes -- a sustained release preparation.
    Eriksson JE; Hanson A; Hörlin R; Johansson BW; Ohlsson O; Otto U; Syrén G
    Acta Med Scand; 1979; 205(1-2):53-9. PubMed ID: 367087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between saliva and serum quinidine concentrations and suppression of ventricular premature beats.
    Ueda CT; Beckmann PJ; Dzindzio BS
    Ther Drug Monit; 1984; 6(1):43-9. PubMed ID: 6200964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of disposition values obtained by two assay methods for quinidine gluconate in patients with ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    Pharmacotherapy; 1989; 9(4):220-5. PubMed ID: 2771807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Livedo racemosa-like photosensitivity reaction during quinidine Durettes medication.
    De Groot WP; Wuite J
    Dermatologica; 1974; 148(6):371-6. PubMed ID: 4418936
    [No Abstract]   [Full Text] [Related]  

  • 76. The second peak in the serum levels curve after oral administration of a slow-release quinidine dosage form: effect of food.
    Spénard J; Sirois G; Gagnon MA
    Br J Clin Pharmacol; 1982 May; 13(5):752-5. PubMed ID: 7082548
    [No Abstract]   [Full Text] [Related]  

  • 77. Comparison of two long-acting forms of quinidine.
    Leizorovicz A; Piolat C; Boissel JP; Sanchini B; Ferry S
    Br J Clin Pharmacol; 1984 Jun; 17(6):729-34. PubMed ID: 6743467
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.
    Puigdemont A; Riu JL; Guitart R; Arboix M
    J Pharmacol Methods; 1990 Apr; 23(2):79-85. PubMed ID: 2332982
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prediction of the disposition of propafenone in humans and dogs from pharmacokinetic parameters in other animal species.
    Puigdemont A; Guitart R; de Mora F; Arboix M
    J Pharm Sci; 1991 Dec; 80(12):1106-9. PubMed ID: 1815066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clearance of quinidine during peritoneal dialysis.
    Hall K; Meatherall B; Krahn J; Penner B; Rabson JL
    Am Heart J; 1982 Sep; 104(3):646-7. PubMed ID: 6180621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.